ArticleFrontiers in immunology2022

Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature Model.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.